Pharming Group N.V.
PHAR
$7.95
-$0.375-4.51%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 160.32M | 213.42M | 197.57M | 192.37M | |
| Total Receivables | 51.12M | 42.62M | 40.52M | 33.16M | |
| Inventory | 59.19M | 56.76M | 53.44M | 53.04M | |
| Prepaid Expenses | -- | 3.54M | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | 212.00K | -- | |
| Total Current Assets | 270.63M | 316.34M | 291.74M | 278.57M | |
|
|
|||||
| Total Current Assets | 270.63M | 316.34M | 291.74M | 278.57M | |
| Net Property, Plant & Equipment | 30.72M | 33.47M | 37.48M | 39.35M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 66.57M | 71.27M | 69.85M | 73.41M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 40.64M | 31.38M | 28.16M | 28.82M | |
| Total Assets | 415.93M | 462.85M | 436.47M | 429.81M | |
|
|
|||||
| Total Accounts Payable | 72.97M | 16.02M | 62.54M | 59.30M | |
| Total Accrued Expenses | -- | 50.27M | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 6.97M | 5.44M | 5.52M | 5.65M | |
| Total Finance Division Other Current Liabilities | -- | 6.23M | -- | -- | |
| Total Other Current Liabilities | -- | 6.23M | -- | -- | |
| Total Current Liabilities | 79.94M | 77.97M | 68.06M | 64.95M | |
|
|
|||||
| Total Current Liabilities | 79.94M | 77.97M | 68.06M | 64.95M | |
| Long-Term Debt | 87.32M | 136.60M | 129.73M | 134.18M | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 27.73M | 29.51M | 28.73M | 30.30M | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 194.99M | 244.07M | 226.53M | 229.43M | |
|
|
|||||
| Common Stock & APIC | 494.60M | 486.10M | 483.63M | 471.90M | |
| Retained Earnings | -273.66M | -267.32M | -273.69M | -271.53M | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 220.94M | 218.78M | 209.94M | 200.37M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 220.94M | 218.78M | 209.94M | 200.37M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 220.94M | 218.78M | 209.94M | 200.37M | |
|
|
|||||
